A. Higham (Manchester (Greater Manchester), United Kingdom), S. Lea (Manchester (Greater Manchester), United Kingdom)
The role of phonophoresis in patients with COPD: a randomized clinical trial
M. Shen (changchun, China)
|   |
Morphine for refractory breathlessness in COPD: a randomized clinical intervention study
C. Verberkt (Maastricht, Netherlands), M. Van Den Beuken-Van Everdingen (Maastricht, Netherlands), J. Schols (Maastricht, Netherlands), N. Hameleers (Maastricht, Netherlands), E. Wouters (Horn, Netherlands), D. Janssen (Horn, Netherlands)
| |
Roflumilast in severely ill patients with chronic obstructive pulmonary disease with frequent exacerbations: real-life outcomes
I. Alispahic (Hellerup, Denmark), R. Sørensen (Copenhagen, Denmark), J. Eklöf (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), A. Løkke (Vejle, Denmark), N. Seersholm (Hellerup, Denmark), J. Vestergaard (Hellerup, Denmark), C. Bergsoe (Hellerup, Denmark), J. Jensen (Hellerup, Denmark), (Hellerup, Denmark)
| |
Effects of bisoprolol and nebivolol on the left ventricular diastolic function in patients (pts) with COPD and stable angina.
O. Fesenko (Dnipro, Ukraine), K. Bohatska (Dnipro, Ukraine)
| |
Omaveloxolone, CDDO-Me and Obacunone as promising therapeutic options in COPD
C. Estornut (Valencia, Spain), P. Ribera (Valencia, Spain), A. Bayarri (Valencia, Spain), P. Montero (Valencia, Spain), J. Cortijo (Valencia, Spain)
| |
Effects of Bauhinia bauhinioides kallikrein proteinase inhibitor in mice with asthma-COPD
L. da Silva (São Paulo, Brazil), J. Barbosa (São Paulo, Brazil), J. João (São Paulo, Brazil), T. Dos Santos (São Paulo, Brazil), L. Camargo (São Paulo, Brazil), E. De Campos (São Paulo, Brazil), T. Galli (São Paulo, Brazil), B. Saraiva-Romanholo (São Paulo, Brazil), S. Bezerra (São Paulo, Brazil), S. Hamaguchi (São Paulo, Brazil), E. Leick (São Paulo, Brazil), C. Prado (São Paulo, Brazil), M. Martins (São Paulo, Brazil), M. Olivo (São Paulo, Brazil), R. Righetti (São Paulo, Brazil), I. Tibério (São Paulo, Brazil)
| |
Inhaled bacterial mimetic increases PAD4-dependent NETosis in the lungs
T. Andreasson (Gothenburg, Sweden), L. Odqvist (Gothenburg, Sweden), S. Arlbrandt (Gothenburg, Sweden), C. Wingren (Gothenburg, Sweden), P. Berntsson (Gothenburg, Sweden), M. Rhedin (Gothenburg, Sweden), M. Dearman (Cambridge, United Kingdom), A. Borde (Gothenburg, Sweden), M. Birrell (Gothenburg, Sweden), A. Åstrand (Gothenburg, Sweden)
| |
Genetics of response to sustained-release morphine for chronic breathlessness - an exploratory study
D. Ferreira (Adelaide (SA), Australia), D. Barratt (Adelaide (SA), Australia), A. Somogyi (Adelaide (SA), Australia), D. Currow (Adelaide (SA), Australia)
| |
Hypertension in chronic obstructive pulmonary disease (COPD): A review of current practice
R. Cooper (Telford, United Kingdom), W. Po Fung (Telford, United Kingdom), A. Perry (Telford, United Kingdom), J. Greenway (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), A. Makan (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom)
| |
Effects of biweekly Alpha1 antitrypsin replacement therapy: a case series
I. Farinha (Coimbra, Portugal), A. Cunha (Coimbra, Portugal), F. Costa (Coimbra, Portugal)
| |
Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting
P. Neto (Porto Alegre (RS), Brazil), B. Spolidoro (Porto Alegre (RS), Brazil), G. Marcolin (Porto Alegre (RS), Brazil), D. Berton (Porto Alegre (RS), Brazil), M. Knorst (Porto Alegre (RS), Brazil)
| |
Impact of the phosphatidylcholine treatment program on the surfactant protein D levels in hypertensive patients with Acute Exacerbations of COPD
O. Shtepa (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine)
| |
Monitoring disease progression in severe Alpha1 antitrypsin deficiency
I. Farinha (Coimbra, Portugal), A. Cunha (Coimbra, Portugal), F. Costa (Coimbra, Portugal)
| |
Ninjin-yoeito ameliorates cigarette smoke-induced skeletal muscle complications in mice
A. Miyamoto (Osaka, Japan), H. Kadotani (Osaka, Japan), K. Asai (Osaka, Japan), N. Maruyama (Osaka, Japan), H. Kubo (Osaka, Japan), A. Okamoto (Osaka, Japan), N. Ijiri (Osaka, Japan), K. Sato (Osaka, Japan), T. Watanabe (Osaka, Japan), K. Hirata (Osaka, Japan), T. Kawaguchi (Osaka, Japan)
| |
Treatment with proteinase inhibitor from Enterolobium contortisiliquum in mice with asthma-COPD
J. Barbosa (São Paulo, Brazil), L. Da Silva (São Paulo, Brazil), J. João (São Paulo, Brazil), T. Dos Santos (São Paulo, Brazil), L. Camargo (São Paulo, Brazil), E. De Campos (São Paulo, Brazil), T. Galli (São Paulo, Brazil), B. Saraiva-Romanholo (São Paulo, Brazil), S. Bezerra (São Paulo, Brazil), S. Hamaguchi (São Paulo, Brazil), E. Leick (São Paulo, Brazil), C. Prado (São Paulo, Brazil), M. Martins (São Paulo, Brazil), M. Olivo (São Paulo, Brazil), R. Righetti (São Paulo, Brazil), I. Tibério (São Paulo, Brazil)
| |
Effect of ICS/LABA combination in an ex vivo model of COPD exacerbation
L. Calzetta (Rome, Italy), B. Ritondo (Rome, Italy), E. Puxeddu (Rome, Italy), M. Matera (Naples, Italy), P. Rogliani (Rome, Italy)
| |